Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136368633> ?p ?o ?g. }
- W3136368633 endingPage "414" @default.
- W3136368633 startingPage "414" @default.
- W3136368633 abstract "S-(+) enantiomer of ibuprofen (IBU) dexibuprofen (DXI) is known to be more potent than its R-(−) form and exhibits many advantages over the racemic mixture of IBU such as lower toxicity, greater clinical efficacy, and lesser variability in therapeutic effects. Moreover, DXI potential has been recently advocated to reduce cancer development and prevent the development of neurodegenerative diseases in addition to its anti-inflammatory properties. During the last decade, many attempts have been made to design novel formulations of DXI aimed at increasing its therapeutic benefits and minimizing the adverse effects. Therefore, this article summarizes pharmacological information about DXI, its pharmacokinetics, safety, and therapeutic outcomes. Moreover, modified DXI drug delivery approaches are extensively discussed. Recent studies of DXI prodrugs and novel DXI nanoformulations are analyzed as well as reviewing their efficacy for ocular, skin, and oral applications." @default.
- W3136368633 created "2021-03-29" @default.
- W3136368633 creator A5003028700 @default.
- W3136368633 creator A5037098813 @default.
- W3136368633 date "2021-03-19" @default.
- W3136368633 modified "2023-10-09" @default.
- W3136368633 title "Dexibuprofen Therapeutic Advances: Prodrugs and Nanotechnological Formulations" @default.
- W3136368633 cites W107765991 @default.
- W3136368633 cites W1480569219 @default.
- W3136368633 cites W1533778123 @default.
- W3136368633 cites W1592872636 @default.
- W3136368633 cites W1890321163 @default.
- W3136368633 cites W1963762892 @default.
- W3136368633 cites W1972300854 @default.
- W3136368633 cites W1972969820 @default.
- W3136368633 cites W1977753291 @default.
- W3136368633 cites W1979180304 @default.
- W3136368633 cites W1981383266 @default.
- W3136368633 cites W1985833024 @default.
- W3136368633 cites W1989363589 @default.
- W3136368633 cites W1994085436 @default.
- W3136368633 cites W1998852309 @default.
- W3136368633 cites W2002076420 @default.
- W3136368633 cites W2010155469 @default.
- W3136368633 cites W2014027092 @default.
- W3136368633 cites W2017755239 @default.
- W3136368633 cites W2021122114 @default.
- W3136368633 cites W2031108968 @default.
- W3136368633 cites W2036264501 @default.
- W3136368633 cites W2040795048 @default.
- W3136368633 cites W2043724786 @default.
- W3136368633 cites W2056661598 @default.
- W3136368633 cites W2089180950 @default.
- W3136368633 cites W2091561837 @default.
- W3136368633 cites W2108882705 @default.
- W3136368633 cites W2112316832 @default.
- W3136368633 cites W2117305511 @default.
- W3136368633 cites W2117817142 @default.
- W3136368633 cites W2130821845 @default.
- W3136368633 cites W2136750283 @default.
- W3136368633 cites W2148511556 @default.
- W3136368633 cites W2151591648 @default.
- W3136368633 cites W2158539348 @default.
- W3136368633 cites W2162613950 @default.
- W3136368633 cites W2163177408 @default.
- W3136368633 cites W2170145492 @default.
- W3136368633 cites W2172800700 @default.
- W3136368633 cites W2319905427 @default.
- W3136368633 cites W2346739591 @default.
- W3136368633 cites W2409041238 @default.
- W3136368633 cites W2433200181 @default.
- W3136368633 cites W2564564443 @default.
- W3136368633 cites W2566827042 @default.
- W3136368633 cites W2588933601 @default.
- W3136368633 cites W2593043147 @default.
- W3136368633 cites W2613674619 @default.
- W3136368633 cites W2729600751 @default.
- W3136368633 cites W2757058370 @default.
- W3136368633 cites W2791747704 @default.
- W3136368633 cites W2883531566 @default.
- W3136368633 cites W2903762622 @default.
- W3136368633 cites W2910919214 @default.
- W3136368633 cites W2916972238 @default.
- W3136368633 cites W2945180101 @default.
- W3136368633 cites W2972727199 @default.
- W3136368633 cites W2982488296 @default.
- W3136368633 cites W2990432892 @default.
- W3136368633 cites W2991437725 @default.
- W3136368633 cites W3003616269 @default.
- W3136368633 cites W3015308147 @default.
- W3136368633 cites W3083836560 @default.
- W3136368633 cites W3088168452 @default.
- W3136368633 cites W70896547 @default.
- W3136368633 cites W828537049 @default.
- W3136368633 doi "https://doi.org/10.3390/pharmaceutics13030414" @default.
- W3136368633 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8003675" @default.
- W3136368633 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33808908" @default.
- W3136368633 hasPublicationYear "2021" @default.
- W3136368633 type Work @default.
- W3136368633 sameAs 3136368633 @default.
- W3136368633 citedByCount "14" @default.
- W3136368633 countsByYear W31363686332021 @default.
- W3136368633 countsByYear W31363686332022 @default.
- W3136368633 countsByYear W31363686332023 @default.
- W3136368633 crossrefType "journal-article" @default.
- W3136368633 hasAuthorship W3136368633A5003028700 @default.
- W3136368633 hasAuthorship W3136368633A5037098813 @default.
- W3136368633 hasBestOaLocation W31363686331 @default.
- W3136368633 hasConcept C102652120 @default.
- W3136368633 hasConcept C108215921 @default.
- W3136368633 hasConcept C112705442 @default.
- W3136368633 hasConcept C171250308 @default.
- W3136368633 hasConcept C192562407 @default.
- W3136368633 hasConcept C197934379 @default.
- W3136368633 hasConcept C19831878 @default.
- W3136368633 hasConcept C2779820397 @default.
- W3136368633 hasConcept C2779944601 @default.
- W3136368633 hasConcept C2780035454 @default.